Company Selected - Sino Biopharmaceutical Ltd - Cashflow Statement

Display Company's Fundamental Data

Display Explanation

Selected Cashflow Statement Currency Units:

Selected Cashflow Statement Format:

Display all periods

Fiscal Year is From January To December - All Figures are in HKD, Thousands	06/30/2025	03/31/2025	12/31/2024	09/30/2024
Hid Net Income	3,871,263	3,685,548	3,499,834	3,258,498
Hid Depreciation	575,692	542,962	510,231.00	510,231.00
Hid Stock Based Compensation	53,721.00	53,721.00	53,721	26,860
Hid Other Non-Cash Items	-1,340,228	-1,162,762	-985,296	-717,100
Hid [-] Change In Working Capital	-	3,078,490.00	3,078,490.00	9,144,224.00
HidHid Change Receivables	-	-	-	-
HidHid Change To Inventory	-	-	-	-
HidHid Change To Liabilities	-	-	-	-
HidHid Change In Other Working Capital	-	-	-	-
Hid Cash Flows Other Operating	-	-	-	-
[-] Total Cash From Operating Activities	3,160,448	3,119,469	3,078,490.00	9,144,224.00
Hid Capital Expenditures	-270,849	-339,172	-407,495	-1,475,318
Hid Investments	-	-	-	-
Hid Other Cashflows From Investing Activities	-	-	-	-
[-] Total Cashflows From Investing Activities	-7,288,667	-4,664,792	-2,040,917.00	-2,797,892.00
Hid Net Borrowings	-	-	-	-3,019,081.00
Hid (+)Sale or (-)Purchase Of Stock	-109,997	-235,774	-361,551.00	-757,944.00
Hid Dividends Paid	-	-	-	-632,669.00
Hid Other Cashflows From Financing Activities	-	-	-	-2,500,847.00
[-] Total Cashflows From Financing Activities	1,576,973	-1,261,245	-4,099,463.00	-10,648,453.00
Hid Begin Period CashFlow	-	-	-	-
Hid Exchange Rate Changes	-	-	-	-
Hid Change In Cash	-	-	-	-
[-] End Period Cash Flow	-	-	-	-
Free Cash Flow to the Firm (FCFF)	3,165,747	3,100,731	2,943,217.87	8,098,342.69
Free Cash Flow to Equity (FCFE)	-	-	-	1,978,830.00